Literature DB >> 15856342

The time-dependent transport of chromium in adult rats from the bloodstream to the urine.

Buffie J Clodfelder1, John B Vincent.   

Abstract

While chromium was proposed to be an essential trace element over 40 years ago and if essential should possess a specific transport and distribution mechanism, the details of its transport from the bloodstream to the urine have not been elucidated. However, chromium is known to be maintained in the bloodstream bound to transferrin and to be excreted in the urine bound to the oligopeptide chromodulin or a similar chromodulin-like species. Injection of (51)Cr-labeled transferrin into the bloodstream resulted in a rapid and insulin-sensitive movement of chromium into the tissues as Cr transferrin; greater than 50% of the Cr is transported to the tissues within 30 min. Tissue levels of Cr are maximal 30 min after injection; decreases in tissue Cr with time are mirrored by increases in urine Cr. Approximately 50% of the (51)Cr appears in the urine within 360 min of injection in the absence of added insulin; insulin treatment concurrent with injection of (51)Cr-labeled transferrin results in approximately 80% of the label appearing in the urine within 180 min. The removal of (51)Cr from the blood is faster than the appearance of (51)Cr in the urine; the lag in time indicates that the Cr transferrin in the blood and Cr in the urine are not in direct equilibrium and that intermediates in the transport of Cr must be involved. This establishes a clear pathway of transport of Cr starting from transport by transferrin from the bloodstream into the tissues, followed by release and processing in the tissues to form chromodulin, excretion into the bloodstream, rapid clearance of chromodulin or a similar species into the urine, and ultimately excretion as this species. Insulin stimulates the processing of Cr in the tissues.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15856342     DOI: 10.1007/s00775-005-0647-3

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  39 in total

1.  CHROMIUM (3) BINDING TO SERUM PROTEINS, SPECIFICALLY SIDEROPHILIN.

Authors:  L L HOPKINS; K SCHWARZ
Journal:  Biochim Biophys Acta       Date:  1964-09-04

2.  The chromium, manganese, and cobalt complexes of transferrin.

Authors:  P Aisen; R Aasa; A G Redfield
Journal:  J Biol Chem       Date:  1969-09-10       Impact factor: 5.157

3.  The inter-relationship between insulin and chromium in hyperinsulinaemic euglycaemic clamps in healthy volunteers.

Authors:  B W Morris; S MacNeil; K Stanley; T A Gray; R Fraser
Journal:  J Endocrinol       Date:  1993-11       Impact factor: 4.286

Review 4.  Current knowledge of iron metabolism.

Authors:  Jose Boccio; Jimena Salgueiro; Alexis Lysionek; Marcela Zubillaga; Ricardo Weill; Cinthia Goldman; Ricardo Caro
Journal:  Biol Trace Elem Res       Date:  2003-06       Impact factor: 3.738

Review 5.  Recent developments in the biochemistry of chromium(III).

Authors:  John B Vincent
Journal:  Biol Trace Elem Res       Date:  2004       Impact factor: 3.738

6.  Urinary chromium excretion of human subjects: effects of chromium supplementation and glucose loading.

Authors:  R A Anderson; M M Polansky; N A Bryden; E E Roginski; K Y Patterson; C Veillon; W Glinsmann
Journal:  Am J Clin Nutr       Date:  1982-12       Impact factor: 7.045

7.  Different metal-binding properties of the two sites of human transferrin.

Authors:  D C Harris
Journal:  Biochemistry       Date:  1977-02-08       Impact factor: 3.162

8.  Kinetics of trace element chromium(III) in the human body.

Authors:  T H Lim; T Sargent; N Kusubov
Journal:  Am J Physiol       Date:  1983-04

9.  Nickel coordination is regulated by the DNA-bound state of NikR.

Authors:  Paul E Carrington; Peter T Chivers; Faizah Al-Mjeni; Robert T Sauer; Michael J Maroney
Journal:  Nat Struct Biol       Date:  2003-02

10.  Metabolic fate of chromium compounds. I. Comparative behavior of chromium in rat administered with Na251CrO4 and 51CrCl3.

Authors:  Y Sayato; K Nakamuro; S Matsui; M Ando
Journal:  J Pharmacobiodyn       Date:  1980-01
View more
  7 in total

1.  Effects of combined dietary chromium(III) propionate complex and thiamine supplementation on insulin sensitivity, blood biochemical indices, and mineral levels in high-fructose-fed rats.

Authors:  Ewelina Król; Zbigniew Krejpcio; Sławomir Michalak; Rafał W Wójciak; Paweł Bogdański
Journal:  Biol Trace Elem Res       Date:  2012-10-16       Impact factor: 3.738

Review 2.  Nutrigenomic basis of beneficial effects of chromium(III) on obesity and diabetes.

Authors:  Francis C Lau; Manashi Bagchi; Chandan K Sen; Debasis Bagchi
Journal:  Mol Cell Biochem       Date:  2008-07-18       Impact factor: 3.396

3.  Significance of conformation changes during the binding and release of chromium(III) from human serum transferrin.

Authors:  Kyle C Edwards; Hannah Kim; Riley Ferguson; Molly M Lockart; John B Vincent
Journal:  J Inorg Biochem       Date:  2020-02-15       Impact factor: 4.155

4.  Evaluation of the acute oral toxicity class of trinuclear chromium(III) glycinate complex in rat.

Authors:  Halina Staniek; Zbigniew Krejpcio; Katarzyna Iwanik; Henryk Szymusiak; Daria Wieczorek
Journal:  Biol Trace Elem Res       Date:  2011-01-18       Impact factor: 3.738

5.  Glucagon and insulin have opposite effects on tissue chromium distribution in an obese mouse model.

Authors:  Chang Lin; Po-Wen Chen; Wen-Ying Chen; Chi-Ching Sun; Frank Chiahung Mao
Journal:  J Diabetes Investig       Date:  2013-05-08       Impact factor: 4.232

6.  The Effects of Supplementary Cr3 (Chromium(III) Propionate Complex) on the Mineral Status in Healthy Female Rats.

Authors:  Halina Staniek; Zbigniew Krejpcio
Journal:  Biol Trace Elem Res       Date:  2017-03-10       Impact factor: 3.738

7.  The Combined Effects of Iron Excess in the Diet and Chromium(III) Supplementation on the Iron and Chromium Status in Female Rats.

Authors:  Halina Staniek; Rafał W Wójciak
Journal:  Biol Trace Elem Res       Date:  2017-11-21       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.